Crystal structure of the catalytic portion of human HMG‐CoA reductase: insights into regulation of activity and catalysis

No abstract is available for this paper.

• Publication year

  2000

• Venue

  EMBO Journal

• Publication date

  2000-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/emboj/19.5.819PMID 10698924PMCID PMC305622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Further additions to MolScript version 1.4, including reading and contouring of electron-density maps.

  1999cited by this paper
• Enhanced 3-hydroxy-3-methyl-glutaryl coenzyme A reductase activity in human colorectal cancer not expressing low density lipoprotein receptor.

  1999cited by this paper
• Sterols regulate cycling of SREBP cleavage-activating protein (SCAP) between endoplasmic reticulum and Golgi.

  1999cited by this paper
• Sequence comparisons reveal two classes of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

  1999cited by this paper
• Aminoethylcysteine can replace the function of the essential active site lysine of Pseudomonas mevalonii 3-hydroxy-3-methylglutaryl coenzyme A reductase.

  1999cited by this paper
• Substrate-induced closure of the flap domain in the ternary complex structures provides insights into the mechanism of catalysis by 3-hydroxy-3-methylglutaryl-CoA reductase.

  1999influential reference
• Rapid automated molecular replacement by evolutionary search.

  1999cited by this paper
• A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood.

  1999cited by this paper
• Oligomerization State Influences the Degradation Rate of 3-Hydroxy-3-methylglutaryl-CoA Reductase*

  1999cited by this paper
• Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21 WAF1/CIP1 in Human Prostate Carcinoma Cells*

  1998cited by this paper
• Crystallography & NMR system: A new software suite for macromolecular structure determination.

  1998influential reference
• Cholesterol lowering in the management of coronary artery disease: the clinical implications of recent trials.

  1998cited by this paper
• The use of SnB to determine an anomalous scattering substructure.

  1998cited by this paper
• Degradation of HMG-CoA Reductase in Vitro

  1998cited by this paper
• HMG-CoA reductase guides migrating primordial germ cells

  1998cited by this paper
• Detecting folding motifs and similarities in protein structures.

  1997cited by this paper
• Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.

  1997cited by this paper
• Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• [33] AMoRe: An automated molecular replacement program package.

  1997cited by this paper
• [20] Processing of X-ray diffraction data collected in oscillation mode.

  1997cited by this paper
• Results of recent large cholesterol-lowering trials and implications for clinical management.

  1997cited by this paper
• The biology of HMG-CoA reductase: the pros of contra-regulation.

  1996cited by this paper
• Degradation of 3-Hydroxy-3-methylglutaryl-CoA Reductase in Endoplasmic Reticulum Membranes Is Accelerated as a Result of Increased Susceptibility to Proteolysis*

  1996cited by this paper
• Inhibition of lung tumor cell growth in vitro and mouse lung tumor formation by lovastatin.

  1996cited by this paper
• Protein-protein interactions: a review of protein dimer structures.

  1995cited by this paper
• How to measure and predict the molar absorption coefficient of a protein

  1995cited by this paper
• NMRPipe: A multidimensional spectral processing system based on UNIX pipes

  1995cited by this paper
• Pharmacology of competitive inhibitors of HMG-CoA reductase.

  1995cited by this paper
• Crystal structure of Pseudomonas mevalonii HMG-CoA reductase at 3.0 angstrom resolution.

  1995cited by this paper
• Molecular Dissection of the Role of the Membrane Domain in the Regulated Degradation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase (*)

  1995cited by this paper
• Phosphorylation of Ser871 impairs the function of His865 of Syrian hamster 3-hydroxy-3-methylglutaryl-CoA reductase.

  1994cited by this paper
• Erratum: Modulation of syrian hamster 3-hydroxy-3-methylglutaryl-CoA reductase activity by phosphorylation. Role of serine 871 (Journal of Biological Chemistry (1994) 269 (6810-6814))

  1994influential reference
• The active site of hamster 3-hydroxy-3-methylglutaryl-CoA reductase resides at the subunit interface and incorporates catalytically essential acidic residues from separate polypeptides.

  1994cited by this paper
• Modulation of Syrian hamster 3-hydroxy-3-methylglutaryl-CoA reductase activity by phosphorylation. Role of serine 871.

  1994cited by this paper
• Catalysis by Syrian hamster 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Proposed roles of histidine 865, glutamate 558, and aspartate 766.

  1994cited by this paper
• Release of proteins and peptides from fusion proteins using a recombinant plant virus proteinase.

  1994influential reference
• His865 is the catalytically important histidyl residue of Syrian hamster 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

  1993cited by this paper
• Importance of mevalonate‐derived products in the control of HMG‐CoA reductase activity and growth of human lung adenocarcinoma cell line a549

  1993cited by this paper
• Calculation of the free energy of association for protein complexes

  1992cited by this paper
• Identification of the catalytically important histidine of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

  1992cited by this paper
• Immunological evidence for eight spans in the membrane domain of 3- hydroxy-3-methylglutaryl coenzyme A reductase: implications for enzyme degradation in the endoplasmic reticulum

  1992cited by this paper
• A novel strategy for production of a highly expressed recombinant protein in an active form

  1991influential reference
• Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons

  1991cited by this paper
• Improved methods for building protein models in electron density maps and the location of errors in these models.

  1991influential reference
• Regulation of the mevalonate pathway

  1990cited by this paper
• Identification of the principal catalytically important acidic residue of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

  1990cited by this paper
• Biochemical aspect of HMG CoA reductase inhibitors.

  1989cited by this paper
• Cloning, sequencing, and overexpression of mvaA, which encodes Pseudomonas mevalonii 3-hydroxy-3-methylglutaryl coenzyme A reductase

  1989cited by this paper
• Multivalent control of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Mevalonate-derived product inhibits translation of mRNA and accelerates degradation of enzyme.

  1988cited by this paper
• In situ determination of the functional size of hepatic 3-hydroxy-3-methylglutaryl-CoA reductase by radiation inactivation analysis.

  1988cited by this paper
• Purification and properties of the catalytic domain of human 3-hydroxy-3-methylglutaryl-CoA reductase expressed in Escherichia coli.

  1988cited by this paper
• Compactin (ML-236B) and related compounds as potential cholesterol-lowering agents that inhibit HMG-CoA reductase.

  1985cited by this paper
• Functional size of rat hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase as determined by radiation inactivation.

  1985cited by this paper
• Mevalonate utilization in Pseudomonas sp. M. Purification and characterization of an inducible 3-hydroxy-3-methylglutaryl coenzyme A reductase.

  1985cited by this paper
• Appearance of crystalloid endoplasmic reticulum in compactin-resistant Chinese hamster cells with a 500-fold increase in 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

  1982cited by this paper
• Molecular cloning of 3-hydroxy-3-methylglutaryl coenzyme a reductase and evidence for regulation of its mRNA.

  1982cited by this paper
• pH properties and chemical mechanism of action of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

  1981cited by this paper
• Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase.

  1978cited by this paper
• 2 Evolutionary and Structural Relationships among Dehydrogenases

  1975cited by this paper
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase. Solubilization and purification of a cold-sensitive microsomal enzyme.

  1973influential reference

• Novel bioavailable hypocholesterolemic peptides derived from milk fermented with Lactococcus lactis NRRL B-50572.

  2026cites this paper
• Unraveling the Antifungal Activity of Hernandulcin: Protective Effect on the Postharvest Rot of Strawberry Receptacles.

  2026cites this paper
• Comprehensive evaluation of isogarcinol from Garcinia cambogia: Extraction, characterization, and docking-based insights into anti-hyperlipidemic potential via HMG-CoA reductase inhibition

  2026cites this paper
• Repurposing of FDA-approved Drugs Identifies Glipizide as a Potent HMG-CoA Reductase Inhibitor: a High-Throughput Virtual Screening and Molecular Dynamics Approach for Targeting Hypercholesterolemia

  2026cites this paper
• Comparative study of palmitoleic acid, sea buckthorn oil, and lovastatin in hepatocellular steatosis model

  2026cites this paper
• Emerging roles of the metabolic regulator 3-hydroxy-3-methylglutaryl coenzyme-CoA reductase in human cancers: From biology to therapeutics

  2025cites this paper
• HMGCR-related muscular dystrophy: a case of severe neonatal-onset form.

  2025cites this paper
• Repurposing Simvastatin and Lovastatin for Colorectal Cancer: An Integrated in-Silico and in-Vitro Study

  2025cites this paper
• Molecular Docking and ADMET Profiling Studies of some Fluorinated Sulfonates and their Schiff Base Derivatives: Potential inhibitors of HMG-CoA Reductase

  2025cites this paper
• Design of Competitive Inhibitory Peptides for 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase.

  2025cites this paper
• Anti-hypercholesterolemia properties of exopolysaccharide from Lactiplantibacillus plantarum MI01: computational and in-vivo approaches

  2025cites this paper
• An oligosaccharide isolated from Rosa canina ameliorates lipid profile and liver damage in MASLD modeled rabbits: in vivo and in silico studies

  2025influential citation
• Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets

  2025cites this paper
• Discovery of Novel Inhibitors of HMG-CoA Reductase Using Bioactive Compounds Isolated From Cochlospermum Species Through Computational Methods: Virtual Screening and Algorithm Validation Study

  2025influential citation
• Functional Properties of the Hydroethanolic Extracts and Main Phenolics of Lactarius indigo and Amanita jacksonii: Millenary Mushrooms Consumed in the Northeastern Highlands of Puebla, Mexico

  2025cites this paper
• Natural Product-Derived Drugs: Structural Insights into Their Biological Mechanisms

  2025cites this paper
• Lipid liquid-crystalline nanoparticles as a suitable platform for accommodating sensitive membrane proteins: monitoring the activity of HMG-CoA reductase

  2025cites this paper
• Cryo-EM structures of apo and atorvastatin-bound human 3-hydroxy-3-methylglutaryl-coenzyme A reductase

  2025cites this paper
• Combinatorial effects of Zingiber officinale and Citrus limon juices: Hypolipidemic and antioxidant insights from in vivo, in vitro, and in silico investigations

  2025cites this paper
• Halophilic archaea produce wax esters and use an alternative fatty acyl-coenzyme A reductase for precursor synthesis

  2025cites this paper
• Incremental modelling and analysis of biological systems with fuzzy hybrid Petri nets

  2024cites this paper
• Comprehensive assessment of phytochemicals and bioactivities in sprouts

  2024cites this paper
• Characterization, structure and inhibition of the human succinyl-CoA:glutarate-CoA transferase, a genetic modifier of glutaric aciduria type 1

  2024cites this paper
• PGC-1α repression dysregulates lipid metabolism and induces lipid droplet accumulation in the retinal pigment epithelium

  2024cites this paper
• Pharmacophore Modeling and Binding Affinity of Secondary Metabolites from Angelica keiskei to HMG Co-A Reductase

  2024influential citation
• In Silico Approach for Identification of Potential Tetracyclic Triterpenoids from Mushroom as HMG-CoA Reductase Inhibitor

  2024cites this paper
• Caryophyllene Oxide, a Bicyclic Terpenoid Isolated from Annona macroprophyllata with Antitumor Activity: In Vivo, In Vitro, and In Silico Studies

  2024cites this paper
• Interferon-α could induce liver steatosis to promote HBsAg loss by increasing triglyceride level

  2024cites this paper
• Repurposing statins for the treatment of larval cestodiases: in silico evaluation of statin-HMG-CoA reductase interactions and assessment of statin effects on a cestode model

  2024cites this paper
• Gold electrode modified with proteoliposome-derived bilayer for electrochemical studies of HMG-CoA Reductase and its inhibition

  2024cites this paper
• The Potential of Flavonoid Derivative Compounds as Inhibitors of the HMG-CoA Reductase Enzyme for Candidate of Hypercholesterolemia Drugs

  2024cites this paper
• The fermented milk can be a natural ally against obesity? Investigation of Bovine Milk Fermentation by Lacticaseibacillus casei LBC 237, Screening, and In Silico Predictions of Bioactive Peptides for Obesity Control

  2024cites this paper
• STUDYING THE HYPOLYPIDEMIC ACTIVITY OF FLAVONOIDS AND ISOFLAVONOIDS OF THE ONONIS ARVENSIS L. METHODS BY IN SILICO

  2024cites this paper
• The metabolic sensor AMPK: Twelve enzymes in one

  2024cites this paper
• Characterization, Structure, and Inhibition of the Human Succinyl-CoA:glutarate-CoA Transferase, a Putative Genetic Modifier of Glutaric Aciduria Type 1.

  2024cites this paper
• UJI IN SILICO TURUNAN KUERSETIN SEBAGAI PENURUN KOLESTEROL LDL DARI KULIT JERUK MANIS (Citrus sinensis)

  2024cites this paper
• Synthesis and Study Medical Application of Nanocomposites Based on grafted Chitosan /Polyvinyl alcohol

  2024cites this paper
• Fabrication of resveratrol-loaded soy peptide nanogels with transglutaminase and in vitro gastrointestinal delivery and cholesterol-lowering effect

  2024cites this paper
• Carbohydrazide-Based schiff bases for selective Hg (II) ion sensing and computational analysis of cholesterol lowering activity

  2024cites this paper
• Design, synthesis, and biological evaluation of novel atorvastatin derivatives

  2023cites this paper
• Genome-wide analysis of the PtHMGR gene family and functional validation of PtHMGR5 improving drought tolerance in Populus trichocarpa

  2023cites this paper
• A molecular informatics and in-vitro approach to evaluate the HMG-CoA reductase inhibitory efficacy of monoterpenes, carvacrol and geraniol

  2023cites this paper
• 3-Hydroxy-3-methylglutaryl coenzyme A reductase genes from Glycine max regulate plant growth and isoprenoid biosynthesis

  2023cites this paper
• Limb girdle muscular disease caused by HMGCR mutation and statin myopathy treatable with mevalonolactone

  2023cites this paper
• Identification of potential bioactive compounds of Passiflora edulis leaf extract against colon adenocarcinoma cells.

  2023cites this paper
• Multitarget Potential of Phytochemicals from Traditional Medicinal Tree, Terminalia arjuna (Roxb. ex DC.) Wight & Arnot as Potential Medicaments for Cardiovascular Disease: An In-Silico Approach

  2023cites this paper
• Hop bitterness in beer evaluated by computational analysis

  2023cites this paper
• Modeling of Hydrophobic Tetrapeptides as a Competitive Inhibitor for HMG-CoA Reductase

  2023cites this paper
• AMFR promotes innate immunity activation and proteasomal degradation of HMGCR in response to influenza virus infection in A549 cells.

  2023cites this paper
• Bi-allelic variants in HMGCR cause an autosomal-recessive progressive limb-girdle muscular dystrophy.

  2023cites this paper
• Targeting Enterococcus faecalis HMG-CoA reductase with a non-statin inhibitor

  2023cites this paper
• 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase (HMGCR) protects hair cells from cisplatin‐induced ototoxicity in vitro: possible relation to the activities of p38 MAPK signaling pathway

  2023cites this paper
• Pharmacogenomics of lipid-lowering agents: the impact on efficacy and safety.

  2022cites this paper
• A resistance-gene-directed tolerance trait and selective inhibitors proffer HMG-CoA reductase as a new herbicide mode of action

  2022cites this paper
• Understanding hypocholesterolemic activity of soy isoflavones: Completing the puzzle through computational simulations

  2022cites this paper
• Model Lipid Raft Membranes for Embedding Integral Membrane Proteins: Reconstitution of HMG-CoA Reductase and Its Inhibition by Statins

  2022cites this paper
• On the Hypolipidemic Activity of Elicited Soybeans: Evidences Based on Computational Analysis

  2022cites this paper
• Enzyme activity inhibition properties of new cellulose nanocrystals from Citrus medica L. Pericarp: A perspective of cholesterol lowering.

  2022cites this paper
• A molecular modeling approach for structure-based virtual screening and identification of novel anti-hypercholesterolemic agents from Grape

  2022cites this paper
• The impact of genetically controlled splicing on exon inclusion and protein structure

  2022cites this paper
• Simvastatin Resistance of Leishmania amazonensis Induces Sterol Remodeling and Cross-Resistance to Sterol Pathway and Serine Protease Inhibitors

  2022cites this paper
• In silico Analysis of the Polyphenolic Metabolites of Zea mays L. "Purple Corn" on HMG-CoA Reductase

  2022cites this paper
• Ligand-based pharmacophore modeling, molecular docking, and molecular dynamic studies of HMG-CoA reductase inhibitors

  2022cites this paper
• A fungal tolerance trait and selective inhibitors proffer HMG-CoA reductase as a herbicide mode-of-action

  2022cites this paper
• Engineering Concanavalin B to Release Bioactive Peptides against Metabolic Syndrome

  2021cites this paper
• Structural insights into the mechanism of human NPC1L1-mediated cholesterol uptake

  2021cites this paper
• Compartmentalisation of Mevalonate Biosynthesis in Evolutionarily Divergent Eukaryotes

  2021cites this paper
• Inhibition of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase enzyme by dipeptides identified in dry-cured ham

  2021cites this paper
• Hepatic Proteomic Analysis Reveals That Enhanced Carboxylic Acid Metabolism and Oxidoreduction Promote Muscle and Fat Deposition in Muscovy Duck

  2021cites this paper
• Glucose restriction drives spatial reorganization of mevalonate metabolism

  2021cites this paper
• Fungal metabolites: a source of bioactive natural products

  2021cites this paper
• A-family anti-inflammatory cyclopentenone prostaglandins: A novel class of non-statin inhibitors of HMG-CoA reductase.

  2021cites this paper
• IAF, QGF, and QDF Peptides Exhibit Cholesterol-Lowering Activity through a Statin-like HMG-CoA Reductase Regulation Mechanism: In Silico and In Vitro Approach

  2021cites this paper
• PyrGF and GSTLN peptides enhance pravastatin's inhibition of 3-hydroxy-3-methyl-glutaryl coenzyme

  2021cites this paper
• Point mutations in Candida glabrata 3-hydroxy-3-methylglutaryl-coenzyme A reductase (CgHMGR) decrease enzymatic activity and substrate/inhibitor affinity

  2021cites this paper
• Enzymes in the Cholesterol Synthesis Pathway: Interactomics in the Cancer Context

  2021cites this paper
• Loose Morphology and High Dynamism of OSER Structures Induced by the Membrane Domain of HMG-CoA Reductase

  2021cites this paper
• Erectcyanthins A-C from marine sponge Hyrtios erectus: anti-dyslipidemic agents attenuate hydroxymethylglutaryl coenzyme A reductase

  2021cites this paper
• Point Mutations In Candida Glabrata 3-Hydroxy-3-Methyl Glutaryl Coenzyme A Reductase (HMGRCg) An Antifungal Target, Decrease Enzymatic Activity And Substrate/Inhibitor Affinity

  2021cites this paper
• Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis.

  2021cites this paper
• An Atomic-Level Perspective of HMG-CoA-Reductase: The Target Enzyme to Treat Hypercholesterolemia

  2020influential citation
• Investigation of HMG‐CoA reductase inhibitory and antioxidant effects of various hydroxycoumarin derivatives

  2020cites this paper
• Inhibition mechanism of 3-hydroxy, 3-methyl glutaryl CoA reductase by tocotrienol-rich rice bran fraction optimally extracted with ultrasonic energy.

  2020cites this paper
• Structural basis for the HMGCR interaction with UBIAD1 mutants causing Schnyder corneal dystrophy

  2020cites this paper
• Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy

  2020influential citation
• Glucose restriction drives spatial re-organization of mevalonate metabolism and liquid-crystalline lipid droplet biogenesis

  2020cites this paper
• Targeting prenylation inhibition through the mevalonate pathway.

  2020cites this paper
• The Modulatory Effect of Cholesterol Synthesis by Oryza sativa Derived Bioactive Peptide Fractions: An In Vitro Investigation

  2020cites this paper
• In silico investigation on alkaloids of Rauwolfia serpentina as potential inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductase

  2020cites this paper
• The effect of lidocaine on gene function and the possibility of side effects

  2020cites this paper
• Inhibitor design for 3‐hydroxy‐3‐methyl‐glutaryl‐CoA reductase enzyme; molecular docking and determination of molecular and electronic properties of ligands by density functional theory method

  2020cites this paper
• Bio analytical method development and validation for Ezetimibe and Pitavastain and its applications to pharmacokinetic studies in Rabbit plasma by using LCMS/MS

  2020cites this paper
• In-silico studies of HMG-Co A reductase inhibitors present in fruits of Withania coagulans Dunal (Solanaceae)

  2020cites this paper
• Exploration of Binding Interaction of Steroidal Drugs with HMG-CoA Reductase for the Treatment of Breast Cancer Patients who suffer with Cardiovascular Problems: In-silico Studies

  2020cites this paper
• Extra Virgin Olive Oil Phenol Extracts Exert Hypocholesterolemic Effects through the Modulation of the LDLR Pathway: In Vitro and Cellular Mechanism of Action Elucidation

  2020cites this paper
• In-Silico Analysis of Methoxyl Pectin Compounds from Banana Peels as HMG-CoA Reductase Inhibitor Complexes

  2020cites this paper
• The Modulatory Effect of Cholesterol Synthesis by Oryza sativa Derived Bioactive Peptide Fractions: An In Vitro Investigation

  2020cites this paper
• The Role of Structure and Biophysical Properties in the Pleiotropic Effects of Statins

  2020cites this paper
• Allantoin, a Potential Metabolite That Promotes AMPK Phosphorylation and Suppresses Cholesterol Biosynthesis Via the Mevalonate Pathway and Bloch Pathway

  2020cites this paper
• Therapeutic targets of hypercholesterolemia: HMGCR and LDLR

  2019cites this paper